TY - JOUR
T1 - Factors Associated with Undiagnosed Open-Angle Glaucoma
T2 - The Thessaloniki Eye Study
AU - Topouzis, Fotis
AU - Coleman, Anne L.
AU - Harris, Alon
AU - Koskosas, Archimidis
AU - Founti, Panayiota
AU - Gong, Gordon
AU - Yu, Fei
AU - Anastasopoulos, Eleftherios
AU - Pappas, Theofanis
AU - Wilson, M. Roy
N1 - Funding Information:
This study was supported by the International Glaucoma Association, London, United Kingdom; University of California Los Angeles Center for Eye Epidemiology, Los Angeles, California; Health Future Foundation, Creighton University, Omaha, Nebraska; Texas Tech University Health Sciences Center, Lubbock, Texas; Pfizer, Inc, New York, New York; Glaucoma Research & Education Foundation, Indianapolis, Indiana; Pharmacia Hellas, Athens, Greece; Novartis Hellas, Athens, Greece; and the 03ED 938 research project, implemented within the framework of the “Reinforcement Programme of Human Research Manpower” (PENED) and co-financed by National and Community Funds (25% from the Greek Ministry of Development-General Secretariat of Research and Technology and 75% from E.U.-European Social Fund). Dr Topouzis is on Glaucoma Advisory Board for Pfizer Ophthalmics and Alcon; Dr Harris received research grant support from Merck and Co, Inc; Dr Coleman received honorarium for lecturing from Pfizer Inc; and Dr Wilson is on Glaucoma Advisory Board for Pfizer Ophthalmics. Involved in design of study (F.T., A.H., A.L.C., M.R.W.); conduct of study (F.T., A.H., A.L.C., M.R.W.); collection of data (F.T., A.K., E.A., T.P.); management (F.T.); analysis and interpretation of the data (F.T., A.H., A.L.C., A.K., P.F., G.G., F.Y., E.A., T.P., M.R.W.); preparation of the manuscript (F.T., A.K., P.F.); and review and approval of the manuscript (F.T., A.H., A.L.C., A.K., P.F., G.G., F.Y., E.A., T.P., M.R.W.). The study was approved by the Aristotle University Medical School Ethics Committee. The Institutional Review Board of the University of California, Los Angeles approved the plans for data analyses. All study procedures adhered to the principles outlined in the Declaration of Helsinki for research involving human subjects and all participants gave written informed consent prior to their participation.
PY - 2008/2
Y1 - 2008/2
N2 - Purpose: To identify factors associated with undiagnosed open-angle glaucoma (OAG), primary open-angle glaucoma (POAG), and pseudoexfoliative glaucoma (PEXG) in an elderly population in Thessaloniki, Greece. Design: Cross-sectional population-based study. Methods: Randomly selected subjects ≥60 years (n = 2,554) participated in the study. Subjects were classified as having POAG or PEXG according to specific criteria and using a two-scale definition of glaucoma. Undiagnosed glaucoma was defined as absence of either prior diagnosis of glaucoma or ocular hypertension or prior medical treatment for glaucoma or prior glaucoma surgery. Logistic regression analyses were performed with age, gender, family history of glaucoma, history of cataract surgery, visual acuity, vertical cup-to-disk (C/D) ratio, intraocular pressure, Advanced Glaucoma Intervention Study visual field score, time since last eye doctor visit, and type of OAG as covariates. Results: The prevalence of undiagnosed glaucoma was 57.1% (56/98) for POAG, significantly higher than the prevalence of 34.9% (15/43) for PEXG (P = .017). POAG patients presented three to four times increased risk to be undiagnosed compared with PEXG patients (P = .02 and P = .04, respectively). Patients with OAG who had not visited an ophthalmologist during the last year had six times an increased risk to be undiagnosed (P = .003). In POAG, smaller vertical C/D ratio was statistically significantly associated with an increased risk to be undiagnosed (P = .008). Conclusions: Lack of regular visits to an ophthalmologist was a major factor for undiagnosed OAG. POAG was more likely to be undiagnosed than PEXG. Since C/D ratio was associated with undiagnosed POAG, standardized protocols involving thorough evaluation of the optic disk are recommended for ophthalmologists.
AB - Purpose: To identify factors associated with undiagnosed open-angle glaucoma (OAG), primary open-angle glaucoma (POAG), and pseudoexfoliative glaucoma (PEXG) in an elderly population in Thessaloniki, Greece. Design: Cross-sectional population-based study. Methods: Randomly selected subjects ≥60 years (n = 2,554) participated in the study. Subjects were classified as having POAG or PEXG according to specific criteria and using a two-scale definition of glaucoma. Undiagnosed glaucoma was defined as absence of either prior diagnosis of glaucoma or ocular hypertension or prior medical treatment for glaucoma or prior glaucoma surgery. Logistic regression analyses were performed with age, gender, family history of glaucoma, history of cataract surgery, visual acuity, vertical cup-to-disk (C/D) ratio, intraocular pressure, Advanced Glaucoma Intervention Study visual field score, time since last eye doctor visit, and type of OAG as covariates. Results: The prevalence of undiagnosed glaucoma was 57.1% (56/98) for POAG, significantly higher than the prevalence of 34.9% (15/43) for PEXG (P = .017). POAG patients presented three to four times increased risk to be undiagnosed compared with PEXG patients (P = .02 and P = .04, respectively). Patients with OAG who had not visited an ophthalmologist during the last year had six times an increased risk to be undiagnosed (P = .003). In POAG, smaller vertical C/D ratio was statistically significantly associated with an increased risk to be undiagnosed (P = .008). Conclusions: Lack of regular visits to an ophthalmologist was a major factor for undiagnosed OAG. POAG was more likely to be undiagnosed than PEXG. Since C/D ratio was associated with undiagnosed POAG, standardized protocols involving thorough evaluation of the optic disk are recommended for ophthalmologists.
UR - http://www.scopus.com/inward/record.url?scp=38349083191&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2007.09.013
DO - 10.1016/j.ajo.2007.09.013
M3 - Article
C2 - 18045565
AN - SCOPUS:38349083191
SN - 0002-9394
VL - 145
SP - 327-335.e1
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 2
ER -